TY - JOUR
T1 - Atomic-resolution structures of discrete stages on the reaction coordinate of the [Fe4S4] enzyme IspG (GcpE)
AU - Quitterer, Felix
AU - Frank, Annika
AU - Wang, Ke
AU - Rao, Guodong
AU - O'Dowd, Bing
AU - Li, Jikun
AU - Guerra, Francisco
AU - Abdel-Azeim, Safwat
AU - Bacher, Adelbert
AU - Eppinger, Jörg
AU - Oldfield, Eric
AU - Groll, Michael
N1 - Publisher Copyright:
© 2015 Elsevier Ltd. All rights reserved.
PY - 2015/6/19
Y1 - 2015/6/19
N2 - IspG is the penultimate enzyme in non-mevalonate biosynthesis of the universal terpene building blocks isopentenyl diphosphate and dimethylallyl diphosphate. Its mechanism of action has been the subject of numerous studies but remained unresolved due to difficulties in identifying distinct reaction intermediates. Using a moderate reducing agent and an epoxide substrate analogue, we were now able to trap and crystallographically characterize various stages in the IspG-catalyzed conversion of 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate into (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate. In addition, the enzyme's structure was determined in complex with several inhibitors. These results, combined with recent electron paramagnetic resonance data, allowed us to deduce a detailed and complete IspG catalytic mechanism, which describes all stages from initial ring opening to formation of (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate via discrete radical and carbanion intermediates. The data presented in this article provide a guide for the design of selective drugs against many prokaryotic and eukaryotic pathogens to which the non-mevalonate pathway is essential for survival and virulence.
AB - IspG is the penultimate enzyme in non-mevalonate biosynthesis of the universal terpene building blocks isopentenyl diphosphate and dimethylallyl diphosphate. Its mechanism of action has been the subject of numerous studies but remained unresolved due to difficulties in identifying distinct reaction intermediates. Using a moderate reducing agent and an epoxide substrate analogue, we were now able to trap and crystallographically characterize various stages in the IspG-catalyzed conversion of 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate into (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate. In addition, the enzyme's structure was determined in complex with several inhibitors. These results, combined with recent electron paramagnetic resonance data, allowed us to deduce a detailed and complete IspG catalytic mechanism, which describes all stages from initial ring opening to formation of (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate via discrete radical and carbanion intermediates. The data presented in this article provide a guide for the design of selective drugs against many prokaryotic and eukaryotic pathogens to which the non-mevalonate pathway is essential for survival and virulence.
KW - Abbreviations MEP methylerythritol phosphate
KW - EPR electron paramagnetic resonance
KW - HMBPP (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate
KW - MEcPP 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate
UR - http://www.scopus.com/inward/record.url?scp=84937764562&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937764562&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2015.04.002
DO - 10.1016/j.jmb.2015.04.002
M3 - Article
C2 - 25868383
AN - SCOPUS:84937764562
SN - 0022-2836
VL - 427
SP - 2220
EP - 2228
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 12
ER -